Pyxis Oncology Insider Trading Activity | NASDAQ:PYXS

Pyxis Oncology Insider Trading Activity | NASDAQ:PYXS | Benzinga

Track the latest Pyxis Oncology insider trading activity. Stay informed on recent buys, sells, and market impact for Pyxis Oncology stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Pyxis Oncology Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

On March 25, 2026, Rachel Humphrey, the company's - sold 15.5K shares for 1.03 each.

Ownership Statistics for Pyxis Oncology Inc

Shares Outstanding

63.355M

Shares Float

46823497.0%

Insider Shares Owned

6.054M

Insider Percentage Owned

9.72%

Institutional Shares Held

4.640M

Institutional Percentage Held

7.32%


Mar 25, 2026	Rachel Humphrey	—	-15.50K	$1.03	-$15.92K	SELL	-16.01%	81.31K	Apr 14 - Apr 21	View
Nov 27, 2024	Pamela Connealy	CFO & COO	88.85K	$1.96	$174.36K	BUY	8.00%	1.20M	Nov 26	View
Sep 28, 2023	Pamela Connealy	CFO AND COO	8.00K	$1.87	$14.96K	BUY	0.99%	818.53K	Sep 28	View
Sep 27, 2023	Jitendra Wadhane	CHIEF ACCOUNTING OFFICER	2.50K	$1.87	$4.67K	BUY	1.11%	226.94K	Sep 27	View
Sep 27, 2023	Pamela Connealy	CFO AND COO	6.43K	$1.85	$11.87K	BUY	0.80%	810.53K	Sep 27	View
Sep 25, 2023	Jitendra Wadhane	CHIEF ACCOUNTING OFFICER	5.00K	$1.77	$8.85K	BUY	2.28%	224.44K	Sep 25	View
Sep 25, 2023	Pamela Connealy	CFO AND COO	12.00K	$1.67	$20.04K	BUY	1.51%	804.11K	Sep 25	View
Sep 22, 2023	Jitendra Wadhane	CHIEF ACCOUNTING OFFICER	2.50K	$1.74	$4.35K	BUY	1.15%	219.44K	Sep 22	View
Sep 22, 2023	Pamela Connealy	CFO AND COO	5.00K	$1.74	$8.70K	BUY	0.64%	792.11K	Sep 22	View
Sep 18, 2023	Lara Sullivan	PRESIDENT AND CEO	-8.64K	$2.10	-$18.16K	SELL	-0.36%	2.40M	Sep 14 - Sep 18	View
Sep 13, 2023	Lara Sullivan	PRESIDENT AND CEO	-212.66K	$2.15	-$456.80K	SELL	-8.10%	2.41M	Sep 11 - Sep 13	View
Mar 21, 2023	PFIZER INC Pfizer Ventures US LLC	10% OWNER	1.81M	$2.76	$5.00M	BUY	34.70%	7.03M	Mar 17	View
Apr 25, 2022	Mark Chin	—	-1.75M	$3.05	-$5.32M	SELL	-100.00%	0.00	Apr 21	View
Dec 09, 2021	Darren S Cline	DIRECTOR	10.00K	$9.39	$93.89K	BUY	∞	10.00K	Dec 08	View
Nov 19, 2021	Thomas Civik	DIRECTOR	15.70K	$12.74	$200.02K	BUY	∞	15.70K	Nov 18	View
Oct 15, 2021	Mark Chin	—	1.75M	$16.00	$5.00M	BUY	∞	1.75M	Oct 13	View
Oct 15, 2021	Cormorant Asset Management LP Bihua Chen Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP	DIRECTOR	1.12M	$16.00	$7.20M	BUY	∞	1.12M	Oct 13	View

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

PYXS Insider Trading News

Director at Pyxis Oncology Acquires Company Stock Options Worth 392,461 Shares

Benzinga Insights

$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Benzinga

Benzinga

Pyxis Oncology Inc Insider Trading Activity